Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma

The aim of the study reported here was to evaluate the feasibility and safety of raltitrexed and nedaplatin with concurrent radiotherapy in patients with unresectable, locally advanced esophageal squamous cell carcinoma (ESCC). Eligible patients were adults with newly diagnosed untreated, unresectab...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medicine (Baltimore) 2020-01, Vol.99 (4), p.e18732-e18732
Hauptverfasser:	Qiu, Xiangnan, Li, Jing, Zhou, Han, Zhang, Meng, Jiang, Changchen, Shen, Zetian, Zhu, XiXu, Li, Aomei, Che, Yuxin, Wu, Tiancong, Wang, Zhen
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antimetabolites, Antineoplastic - administration & dosage Antimetabolites, Antineoplastic - adverse effects Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Chemoradiotherapy - methods Clinical Trial/Experimental Study Dose-Response Relationship, Radiation Esophageal Neoplasms - pathology Esophageal Neoplasms - therapy Esophageal Squamous Cell Carcinoma - pathology Esophageal Squamous Cell Carcinoma - therapy Female Humans Longitudinal Studies Male Middle Aged Organoplatinum Compounds - administration & dosage Organoplatinum Compounds - adverse effects Quinazolines - administration & dosage Quinazolines - adverse effects Retrospective Studies Thiophenes - administration & dosage Thiophenes - adverse effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!